A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
The trial will assess the efficacy and safety of the system in individuals with movement disorders such as Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback